Drug used to reduce blood fats may cut SARS-CoV-2 infection by 70 per cent: Study

The team led by researchers from the University of Birmingham in the UK found that an oral drug used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent.

An oral drug used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, according to a lab study published on August 6. The team led by researchers from the University of Birmingham in the UK found that fenofibrate and its active form fenofibric acid can significantly reduce SARS-COV-2 infection, which causes Covid-19, in human cells in the laboratory.